Smith & Nephew plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Smith & Nephew plc - ADR: Is Infosys Ltd. worth buying?
Item: Smith & Nephew plc - ADR
Rating: 1.41183325
Author: Trendlyne DVM scores

about

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

32.54 -0.03 (-0.09%)

37.36% Gain from 52W Low

531.0K

XNYS Volume

XNYS 18 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Neutral

47.6 / 100

1Yr Price target upside is 14%

5 analysts

Smith Nephew plc ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Smith & Nephew plc - ADR Live Stock Price Today, Share Analysis and Chart

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medici...

37.36% Gain from 52W Low

SWOT Analysis

Smith Nephew plc ADR Live Price Chart